Minerva Neurosciences | NERV - Employees Total Number

Stock Price
6.18
Daily Change
0.14 2.32%
Monthly
-0.80%
Yearly
231.37%
Q1 Forecast
7.31

Minerva Neurosciences reported 9 in Employees for its fiscal year ending in December of 2023.





Employees Change Date
Acadia Pharmaceuticals 653 56 Dec/2024
Adma Biologics 624 7 Dec/2023
ALKERMES 1.8K 300 Dec/2024
Alterity Therapeutics Limited AUD 12 1 Jun/2022
AstraZeneca USD 89.9K 6.4K Dec/2023
BioCryst Pharmaceuticals 536 5 Dec/2023
Bristol-Myers Squibb 34.1K 0 Dec/2024
Cipla 30.31K 2.55K Dec/2025
Clal Biotechnology 3 191 Dec/2023
Compugen USD 74 6 Dec/2024
CSL USD 32.06K 1.67K Dec/2025
Eli Lilly 47K 4K Dec/2024
Esperion Therapeutics 240 41 Dec/2023
GlaxoSmithKline 69.4K 20.7K Dec/2022
Grifols EUR 23.83K 89 Dec/2024
Halozyme Therapeutics 350 23 Dec/2024
Ionis Pharmaceuticals 1.07K 142 Dec/2024
J&J 138.1K 6.2K Dec/2024
Merck 75K 3K Dec/2024
Minerva Neurosciences 9 0 Dec/2023
Neurocrine Biosciences 1.8K 400 Dec/2024
Novartis USD 101.7K 2.62K Dec/2022
Novavax 1.54K 449 Dec/2023
Pfizer 81K 7K Dec/2024
Roche Holding 103.61K 2.69K Dec/2022
Sanofi 84.59K 3.41K Dec/2024
Takeda 47.46K 1.83K Dec/2025
Vanda Pharmaceuticals 203 87 Dec/2023